Loading clinical trials...
Loading clinical trials...
Advancing Prevention of Pulmonary Fibrosis - A Cohort Study of Preclinical Pulmonary Fibrosis
This study plans to learn more about pulmonary fibrosis and how it develops. We want to determine if the disease can be detected early, before the lung is permanently scarred. This study will enroll participants who are not currently diagnosed with pulmonary fibrosis, but who have family members with pulmonary fibrosis. Because there is an increased risk within affected families, this cohort will allow us to learn how pulmonary fibrosis develops, and how the lungs change over time.
Age
40 - 75 years
Sex
ALL
Healthy Volunteers
Yes
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Start Date
January 22, 2021
Primary Completion Date
August 1, 2026
Completion Date
August 1, 2026
Last Updated
March 25, 2025
800
ESTIMATED participants
Sample collection
OTHER
Questionnaires
OTHER
High resolution CT scan of the chest
RADIATION
Pulmonary Function Test
DIAGNOSTIC_TEST
Lead Sponsor
University of Colorado, Denver
Collaborators
NCT07360600
NCT06860594
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions